Doctors tested a new medicine called darolutamide in a trial with four hundred seventy two men. These men had advanced prostate cancer that had spread to other parts of their body. They received the new drug along with standard treatments like hormone therapy and chemotherapy. Another group received a fake pill instead to compare results fairly.
The main goal was to see if patients lived longer. The results showed that the risk of dying was reduced by thirty seven percent for those taking the real medicine. This means the new drug helped keep patients alive longer than the standard treatment alone.
Other good news included delays in the cancer becoming resistant to hormones and in pain getting worse. Patients also waited longer before needing more strong cancer medicines. The new drug was well tolerated by most people in the study.
Fewer serious side effects occurred with the new drug compared to the fake pill. This suggests the treatment is safe and effective for many patients. Overall, this study offers hope for men with this difficult type of cancer.